Sodium-glucose co-transporter 2 inhibitors for the prevention of heart failure in type 2 diabetes: A systematic review and meta-analysis

Eur J Prev Cardiol. 2020 Apr;27(6):667-670. doi: 10.1177/2047487319841936. Epub 2019 Apr 9.

Authors

Naser Yamani¹, Muhammad Shariq Usman², Tauseef Akhtar¹, Kaneez Fatima², Nisar Asmi¹, Muhammad Shahzeb Khan¹

Affiliations

¹ Internal Medicine, John H Stroger Jr Hospital of Cook County, USA.
² Internal Medicine, Dow University of Health Sciences, Pakistan.

PMID: 30966822
DOI: 10.1177/2047487319841936

No abstract available

Publication types

Letter
Meta-Analysis
Systematic Review

MeSH terms

Aged
Diabetes Mellitus, Type 2 / diagnosis
Diabetes Mellitus, Type 2 / drug therapy*
Diabetes Mellitus, Type 2 / epidemiology
Female
Heart Failure / diagnosis
Heart Failure / epidemiology
Heart Failure / prevention & control*
Hospitalization
Humans
Incidence
Male
Middle Aged
Risk Assessment
Risk Factors
Sodium-Glucose Transporter 2 Inhibitors / adverse effects
Sodium-Glucose Transporter 2 Inhibitors / therapeutic use*
Treatment Outcome

Substances

Sodium-Glucose Transporter 2 Inhibitors